VOYJF yields 4.20% · JNJ yields 2.13%● Live data
📍 VOYJF pulled ahead of the other in Year 1
Combined, VOYJF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VOYJF + JNJ for your $10,000?
Valmet Oyj develops and supplies process technologies, automation, and services for the pulp, paper, and energy industries. The company offers solutions and services for the pulping industry, including chemical pulping, wood handling, cooking and fiber line, pulp drying, chemical recovery, air emission control, other value-adding processes, dissolving pulping, mechanical pulping, recycled fiber, and automation for pulp. It also provides technologies, automation products, and services for board and paper production, such as recycled fiber, stock preparation, board and paper machines, services for board and paper, and automation for board and paper; and technologies, automation products, and services for tissue production. In addition, the company offers energy solutions, BFB and CFB boilers, gasifiers, power and heating plants, air emission control, industrial internet solutions, and services and automation for energy. It serves alternative fuels, biofuels and biomaterials, chemical, fiberboard, filtration, food, laundry, marine, minerals and metals, nonwovens, paper converting, petrochemical, and pharmaceuticals industries. Valmet Oyj is headquartered in Espoo, Finland.
Full VOYJF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.